survival (version 2.41-2)

bladder: Bladder Cancer Recurrences

Description

Data on recurrences of bladder cancer, used by many people to demonstrate methodology for recurrent event modelling. Bladder1 is the full data set from the study. It contains all three treatment arms and all recurrences for 118 subjects; the maximum observed number of recurrences is 9. Bladder is the data set that appears most commonly in the literature. It uses only the 85 subjects with nonzero follow-up who were assigned to either thiotepa or placebo, and only the first four recurrences for any patient. The status variable is 1 for recurrence and 0 for everything else (including death for any reason). The data set is laid out in the competing risks format of the paper by Wei, Lin, and Weissfeld. Bladder2 uses the same subset of subjects as bladder, but formatted in the (start, stop] or Anderson-Gill style. Note that in transforming from the WLW to the AG style data set there is a quite common programming mistake that leads to extra follow-up time for 12 subjects: all those with follow-up beyond their 4th recurrence). Over this extended time these subjects are by definition not at risk for another event in the WLW data set.

Usage

bladder1
bladder
bladder2

Arguments

Format

bladder1
id: Patient id
treatment: Placebo, pyridoxine (vitamin B6), or thiotepa
number: Initial number of tumours (8=8 or more)
size: Size (cm) of largest initial tumour
recur: Number of recurrences
start,stop: The start and end time of each time interval
status: End of interval code, 0=censored, 1=recurrence,
2=death from bladder disease, 3=death other/unknown cause
rtumor: Number of tumors found at the time of a recurrence
rsize: Size of largest tumor at a recurrence
enum: Event number (observation number within patient)
bladder
id: Patient id
rx: Treatment 1=placebo 2=thiotepa
number: Initial number of tumours (8=8 or more)
size: size (cm) of largest initial tumour
stop: recurrence or censoring time
enum: which recurrence (up to 4)
bladder2
id: Patient id
rx: Treatment 1=placebo 2=thiotepa
number: Initial number of tumours (8=8 or more)
size: size (cm) of largest initial tumour
start: start of interval (0 or previous recurrence time)
stop: recurrence or censoring time
enum: which recurrence (up to 4)